{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:43:16Z","timestamp":1789879396404,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00404-010-1747-z","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T07:10:36Z","timestamp":1290582636000},"page":"989-998","source":"Crossref","is-referenced-by-count":6,"title":["Human papillomavirus genotype distribution in cervical samples collected in routine clinical practice at the Nantes University Hospital, France"],"prefix":"10.1007","volume":"284","author":[{"given":"Edouard","family":"Vaucel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Coste-Burel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Laboisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Dahlab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,25]]},"reference":[{"key":"1747_CR1","first-page":"1877","volume":"56","author":"V Dalstein","year":"2006","unstructured":"Dalstein V, Briolat J, Birembaut P, Clavel C (2006) The epidemiology of genital human papillomavirus infections. Rev Prat 56:1877\u20131881","journal-title":"Rev Prat"},{"key":"1747_CR2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jadohealth.2005.09.011","volume":"37","author":"AB Moscicki","year":"2005","unstructured":"Moscicki AB (2005) Impact of HPV infection in adolescent populations. J Adolesc Health 37:S3\u2013S9","journal-title":"J Adolesc Health"},{"key":"1747_CR3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.ogx.0000221010.82943.8c","volume":"61","author":"D Wiley","year":"2006","unstructured":"Wiley D, Masongsong E (2006) Human papillomavirus: the burden of infection. Obstet Gynecol Surv 61:S3\u2013S14","journal-title":"Obstet Gynecol Surv"},{"key":"1747_CR4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244\u2013265","journal-title":"J Clin Pathol"},{"key":"1747_CR5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J et al (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796\u2013802","journal-title":"J Natl Cancer Inst"},{"key":"1747_CR6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"1747_CR7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/91.3.252","volume":"91","author":"P Holowaty","year":"1999","unstructured":"Holowaty P, Miller AB, Rohan T, To T (1999) Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 91:252\u2013258","journal-title":"J Natl Cancer Inst"},{"key":"1747_CR8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/1055-9965.EPI-06-0846","volume":"16","author":"RP Insinga","year":"2007","unstructured":"Insinga RP, Dasbach EJ, Elbasha EH, Liaw KL, Barr E (2007) Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives. Cancer Epidemiol Biomarkers Prev 16:709\u2013715","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1747_CR9","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/587698","volume":"197","author":"H Trottier","year":"2008","unstructured":"Trottier H, Mahmud S, Prado JC, Sobrinho JS, Costa MC, Rohan TE et al (2008) Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis 197:1436\u20131447","journal-title":"J Infect Dis"},{"issue":"Suppl 3","key":"1747_CR10","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.vaccine.2006.06.018","volume":"24","author":"AB Moscicki","year":"2006","unstructured":"Moscicki AB, Schiffman M, Kjaer S, Villa LL (2006) Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 24(Suppl 3):S42\u2013S51","journal-title":"Vaccine"},{"key":"1747_CR11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"1747_CR12","unstructured":"Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P (2010) Cancer incidence and mortality in France over the period 1980\u20132005. Rev \u00c9pidemiol Sant\u00e9 Publique (in press)"},{"key":"1747_CR13","unstructured":"Guizard AV, Tr\u00e9tarre B (2008) Col de l\u2019ut\u00e9rus. In: R\u00e9seau fran\u00e7ais des registres de cancer, Hospices civils de Lyon, Inserm, Invs (eds) Estimation de l\u2019incidence et de la mortalit\u00e9 par cancer en France de 1980 \u00e0 2005. Francim, HCL, Inserm, InVS. Saint-Maurice. http:\/\/www.invs.sante.fr\/surveillance\/cancers\/estimations_cancers . Consult\u00e9 le 21 May 2008"},{"key":"1747_CR14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","volume":"6","author":"LL Villa","year":"2005","unstructured":"Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR et al (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6:271\u2013278","journal-title":"Lancet Oncol"},{"key":"1747_CR15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1086\/590560","volume":"47","author":"F Aubin","year":"2008","unstructured":"Aubin F, Pretet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F et al (2008) Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis 47:610\u2013615","journal-title":"Clin Infect Dis"},{"key":"1747_CR16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ygyno.2008.04.012","volume":"110","author":"JL Pretet","year":"2008","unstructured":"Pretet JL, Jacquard AC, Saunier M, Clavel C, Dachez R, Gondry J et al (2008) Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2\/3 and invasive cervical cancer: the EDiTH III study. Gynecol Oncol 110:179\u2013184","journal-title":"Gynecol Oncol"},{"key":"1747_CR17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ijc.23093","volume":"122","author":"JL Pretet","year":"2008","unstructured":"Pretet JL, Jacquard AC, Carcopino X, Monnier-Benoit S, Averous G, Soubeyrand B et al (2008) Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2\/3) in France: EDITH study. Int J Cancer 122:424\u2013427","journal-title":"Int J Cancer"},{"key":"1747_CR18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ijc.23092","volume":"122","author":"JL Pretet","year":"2008","unstructured":"Pretet JL, Jacquard AC, Carcopino X, Charlot JF, Bouhour D, Kantelip B et al (2008) Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer 122:428\u2013432","journal-title":"Int J Cancer"},{"key":"1747_CR19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/clinchem\/45.7.982","volume":"45","author":"I Laurendeau","year":"1999","unstructured":"Laurendeau I, Bahuau M, Vodovar N, Larramendy C, Olivi M, Bieche I et al (1999) TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clin Chem 45:982\u2013986","journal-title":"Clin Chem"},{"key":"1747_CR20","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D, Davey D, Kurman R, Moriarty A, O\u2019Connor D, Prey M et al (2002) The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287:2114\u20132119","journal-title":"JAMA"},{"key":"1747_CR21","unstructured":"Tumours of the uterine cervix. In: F Tavassoli, P Devilee (eds) Tumours of the breast and female genital organs. WHO classification of tumours. IARC Press, Lyon, 2003"},{"key":"1747_CR22","first-page":"5","volume":"2","author":"C Bergeron","year":"2005","unstructured":"Bergeron C, Cartier I, Guldner L, Lassalle M, Savignoni A, Asselain B (2005) L\u00e9sions pr\u00e9canc\u00e9reuses et cancers du col de l\u2019ut\u00e9rus diagnostiqu\u00e9s par le frottis cervical. Ile-de-France, enqu\u00eate Crisap, 2002. Bull Epidemiol Hebd 2:5\u20136","journal-title":"Bull Epidemiol Hebd"},{"key":"1747_CR23","first-page":"4","volume":"1","author":"C Bergeron","year":"2007","unstructured":"Bergeron C, Cohet C, Bou\u00e9e S, Lorans C, R\u00e9my V (2007) Management of abnormal smears intraepithelial neoplasia and associated treatment costs in France. Bull Epidemiol Hebd 1:4\u20136","journal-title":"Bull Epidemiol Hebd"},{"key":"1747_CR24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e3181996ffa","volume":"113","author":"PE Castle","year":"2009","unstructured":"Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Kinney W (2009) Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol 113:595\u2013600","journal-title":"Obstet Gynecol"},{"key":"1747_CR25","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1054\/bjoc.2001.1845","volume":"84","author":"C Clavel","year":"2001","unstructured":"Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M et al (2001) Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 84:1616\u20131623","journal-title":"Br J Cancer"},{"key":"1747_CR26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.gyobfe.2004.01.013","volume":"32","author":"JC Boulanger","year":"2004","unstructured":"Boulanger JC, Sevestre H, Bauville E, Ghighi C, Harlicot JP, Gondry J (2004) Epidemiology of HPV infection. Gynecol Obstet Fertil 32:218\u2013223","journal-title":"Gynecol Obstet Fertil"},{"key":"1747_CR27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S Sanjose de","year":"2007","unstructured":"de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N et al (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453\u2013459","journal-title":"Lancet Infect Dis"},{"key":"1747_CR28","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1128\/JCM.40.3.902-907.2002","volume":"40","author":"F Coutlee","year":"2002","unstructured":"Coutlee F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N et al (2002) Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902\u2013907","journal-title":"J Clin Microbiol"},{"issue":"Suppl 10","key":"1747_CR29","doi-asserted-by":"crossref","first-page":"K42","DOI":"10.1016\/j.vaccine.2008.05.002","volume":"26","author":"PE Gravitt","year":"2008","unstructured":"Gravitt PE, Coutlee F, Iftner T, Sellors JW, Quint WG, Wheeler CM (2008) New technologies in cervical cancer screening. Vaccine 26(Suppl 10):K42\u2013K52","journal-title":"Vaccine"},{"key":"1747_CR30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","volume":"38","author":"PE Gravitt","year":"2000","unstructured":"Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A et al (2000) Improved amplification of genital human papillomaviruses. J Clin Microbiol 38:357\u2013361","journal-title":"J Clin Microbiol"},{"key":"1747_CR31","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/JCM.35.6.1304-1310.1997","volume":"35","author":"W Qu","year":"1997","unstructured":"Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS et al (1997) PCR detection of human papillomavirus: comparison between MY09\/MY11 and GP5+\/GP6+ primer systems. J Clin Microbiol 35:1304\u20131310","journal-title":"J Clin Microbiol"},{"key":"1747_CR32","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/sj.bjc.6604972","volume":"100","author":"N Munoz","year":"2009","unstructured":"Munoz N, Hernandez-Suarez G, Mendez F, Molano M, Posso H, Moreno V et al (2009) Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer 100:1184\u20131190","journal-title":"Br J Cancer"},{"key":"1747_CR33","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","volume":"14","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM (2005) Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14:1157\u20131164","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00404-010-1747-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T01:25:57Z","timestamp":1636853157000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-010-1747-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,25]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1747"],"URL":"https:\/\/doi.org\/10.1007\/s00404-010-1747-z","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,25]]}}}